rifaximinbeta-blockersdiureticscirrhosistertiary hepatology centre
…s) and liver-related pharmacotherapy (beta-blockers, diuretics, rifaximin) were collected. Models using baseline variables to predict 6-m…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 2,221–2,280 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
betablockers2biologic disease-modifying antirheumatic drugs2botensilimab2brivaracetam2calcium channel blocker2capsule sponge2carbon tetrachloride2ceftazidime-avibactam2cephalexin2chemo-IO2chlorpromazine2chondroitin sulfate2ciclesonide2ciltacabtagene autoleucel2cinacalcet2clodronate liposomes2clomipramine2colchicine-resistant2coumadin2covid vaccines2cross sex hormones2cyclosporine A2darunavir2deferasirox2deferoxamine2desvenlafaxine2dimercaprol2direct oral anticoagulant2docosahexaenoic acid2dolutegravir-based2drug-eluting stents2emergency medications2endothelin-receptor antagonists2eribulin2essential antibiotics2ferric derisomaltose2fibrates2fluoride2fluticasone furoate2fluticasone propionate2fomepizole2fonofos2fostamatinib2furazolidone2galantamine2garlic2glucagon-like peptide-1 (GLP-1) agonists2glucocorticoid-related2glycopeptides2glycoprotein IIb/IIIa2glycopyrronium bromide2hallucinogens2high caffeine2high dose steroids2high-dose statins2high-flow oxygen2hormone blockers2hydrocodone2hydroxyzine2hyoscine butylbromide2
Articles mentioning drugs
10,506 articles · page 400 of 876SeHCATFunctional Bowel Diseasemicroscopic colitiscoeliac diseaseirritable bowel syndromeidiopathic BADCrohn’s disease
… groups 65 (29.1%) severe (<5% retention), 63 (28.2%) moderate (SeHCAT 5-10%), 47 (SeHCAT 10-15%) mild, 48 borderline (SeHCAT 15-20%).…
programmed cell death protein 1programmed death-ligand 1cytotoxic T-lymphocyte-associated protein 4cancerUS Veteran Health Administration
…inistration who received first-line or second-line ICI therapy (programmed cell death protein 1, programmed death-ligand 1, cytotoxic T-lymphocyte-associated p…
FIB-4NHS EnglandLiver diseaseMASLDARLDcACLDT2DMviral hepatitishepatocellular carcinoma
… results for patients who followed the pathway as per protocol. FIB-4 testing demonstrated reduced sensitivity in individuals with T2…
disitamab vedotintrastuzumab deruxtecanT-DXdgastric canceranti-HER2 therapy
…ody-drug conjugates, such as trastuzumab deruxtecan (T-DXd) and disitamab vedotin (RC48), has been pivotal in rendering ‘HER-2-low’ gastric cance…
bisphosphonatesrisedronatecirrhosisNOGGFRAX score
…ad high-risk endoscopic findings and were not suitable for oral bisphosphonates therapy. Four of these patients were treated with a single dose…
CeftriaxoneThird generation cephalosporinTGCdecompensated liver diseaseHepatitis CAFIThe Indus Hospital and Health Network
…cted on consecutive subjects with AFI who received of injection Ceftriaxone from January 2021 till September 2025 at The Indus Hospital and…
midazolamfentanylPropofolGORDgastro-oesophageal reflux disease (GORD)IRAS 304275
…, independent of reflux status.There was no correlation between midazolam or fentanyl dose and DI (all p>0.25). FLIP motility patterns we…
NSAIDfcSEMSNorth Bristol NHS TrustRoyal United Hospitals BathPEPERCP
… Due to inconsistent data, we could not adjust for prophylactic NSAID use or pancreatic stent placement, although almost all patients…
5ASAantiTNFCrohn’s diseaseCROCOBDISS monotherapy
…rianal involvement.Within six months of diagnosis, 18% received 5ASA, 30% systemic corticosteroids, 36% immunosuppressants, and 61% …
Etrasimodulcerative colitisUC
…Introduction Etrasimod is a novel oral selective S1PR modulator recommended for induct…
Tofacitinib15-ASA13Steroids2Crohn’s disease9ulcerative colitisCrohn’s diseaseVillous changesIndeterminate colitis3Villous changes30indeterminate colitis+1 more
…ry sclerosing cholangitis4 (8%)Baseline therapyBiologics26 (53%)Tofacitinib1 (2%)5-ASA13 (27%)Steroids2 (4%)No therapy7 (14%)Mayo Score at i…